China SXT Pharmaceuticals (SXTC) Total Non-Current Liabilities (2019 - 2025)

China SXT Pharmaceuticals' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $158263.0 for Q3 2025.

• In Q3 2025, Total Non-Current Liabilities fell 46.89% year-over-year to $158263.0; the TTM figure through Sep 2025 stood at $158263.0 (down 46.89% YoY), while the FY2025 annual figure was $211683.0, down 28.16% from the prior year.
• Total Non-Current Liabilities was $158263.0 for Q3 2025 at China SXT Pharmaceuticals, down from $211683.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $365823.0 in Q1 2023 to a low of $6292.0 in Q1 2021.
• Historically, Total Non-Current Liabilities has averaged $235178.7 across 4 years, with a median of $294667.0 in 2024.
• The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities slumped 82.77% in 2021, then decreased 4.33% in 2024.
• A 4-year view of Total Non-Current Liabilities shows it stood at $6292.0 in 2021, then jumped by 4850.92% to $311512.0 in 2023, then decreased by 4.33% to $298011.0 in 2024, then tumbled by 46.89% to $158263.0 in 2025.
• The last three Total Non-Current Liabilities figures came in at $158263.0 (Q3 2025), $211683.0 (Q1 2025), and $298011.0 (Q3 2024), per Business Quant data.